Active Ingredient: RIFAMYCIN SODIUM
Proprietary Name: AEMCOLO
Dosage Form; Route of Administration: TABLET, DELAYED RELEASE; ORAL
Strength: EQ 194MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N210910
Product Number: 001
Approval Date: Nov 16, 2018
Applicant Holder Full Name: REDHILL BIOPHARMA INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
